Annual D&A
$83.10 K
+$7400.00+9.78%
September 30, 2024
Summary
- As of February 6, 2025, SONN annual depreciation & amortization is $83.10 thousand, with the most recent change of +$7400.00 (+9.78%) on September 30, 2024.
- During the last 3 years, SONN annual D&A has fallen by -$12.10 thousand (-12.71%).
- SONN annual D&A is now -12.71% below its all-time high of $95.20 thousand, reached on September 30, 2021.
Performance
SONN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$21.60 K
+$600.00+2.86%
September 30, 2024
Summary
- As of February 6, 2025, SONN quarterly depreciation & amortization is $21.60 thousand, with the most recent change of +$600.00 (+2.86%) on September 30, 2024.
- Over the past year, SONN quarterly D&A has increased by +$600.00 (+2.86%).
- SONN quarterly D&A is now -97.39% below its all-time high of $827.40 thousand, reached on March 31, 2020.
Performance
SONN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$83.10 K
+$2100.00+2.59%
September 30, 2024
Summary
- As of February 6, 2025, SONN TTM depreciation & amortization is $83.10 thousand, with the most recent change of +$2100.00 (+2.59%) on September 30, 2024.
- Over the past year, SONN TTM D&A has increased by +$2100.00 (+2.59%).
- SONN TTM D&A is now -90.23% below its all-time high of $850.20 thousand, reached on December 31, 2020.
Performance
SONN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
SONN Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +9.8% | +2.9% | +2.6% |
| 3 y3 years | -12.7% | +2.9% | +2.6% |
| 5 y5 years | +100.0% | +2.9% | +2.6% |
SONN Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -12.7% | +9.8% | -17.6% | +20.7% | -17.3% | +12.0% |
| 5 y | 5-year | -12.7% | -100.0% | -97.4% | +20.7% | -90.2% | +79.5% |
| alltime | all time | -12.7% | -100.0% | -97.4% | +20.7% | -90.2% | +79.5% |
Sonnet BioTherapeutics Holdings Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | $83.10 K(+9.8%) | $21.60 K(+2.9%) | $83.10 K(+2.6%) |
| Jun 2024 | - | $21.00 K(+2.4%) | $81.00 K(+2.5%) |
| Mar 2024 | - | $20.50 K(+2.5%) | $79.00 K(+2.1%) |
| Dec 2023 | - | $20.00 K(+2.6%) | $77.40 K(+2.1%) |
| Sep 2023 | $75.70 K(-18.9%) | $19.50 K(+2.6%) | $75.80 K(+2.2%) |
| Jun 2023 | - | $19.00 K(+0.5%) | $74.20 K(-6.0%) |
| Mar 2023 | - | $18.90 K(+2.7%) | $78.90 K(-8.5%) |
| Dec 2022 | - | $18.40 K(+2.8%) | $86.20 K(-7.5%) |
| Sep 2022 | $93.30 K | $17.90 K(-24.5%) | $93.20 K(-6.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $23.70 K(-9.5%) | $100.10 K(-0.4%) |
| Mar 2022 | - | $26.20 K(+3.1%) | $100.50 K(+2.8%) |
| Dec 2021 | - | $25.40 K(+2.4%) | $97.80 K(+2.7%) |
| Sep 2021 | $95.20 K(+63.3%) | $24.80 K(+2.9%) | $95.20 K(+35.2%) |
| Jun 2021 | - | $24.10 K(+2.6%) | $70.40 K(+52.1%) |
| Mar 2021 | - | $23.50 K(+3.1%) | $46.30 K(-94.6%) |
| Dec 2020 | - | $22.80 K(-97.2%) | $850.20 K(+2.8%) |
| Sep 2020 | $58.30 K(>+9900.0%) | - | - |
| Mar 2020 | - | $827.40 K | $827.40 K |
| Sep 2019 | $0.00 | - | - |
FAQ
- What is Sonnet BioTherapeutics Holdings annual depreciation & amortization?
- What is the all time high annual D&A for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings annual D&A year-on-year change?
- What is Sonnet BioTherapeutics Holdings quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings quarterly D&A year-on-year change?
- What is Sonnet BioTherapeutics Holdings TTM depreciation & amortization?
- What is the all time high TTM D&A for Sonnet BioTherapeutics Holdings?
- What is Sonnet BioTherapeutics Holdings TTM D&A year-on-year change?
What is Sonnet BioTherapeutics Holdings annual depreciation & amortization?
The current annual D&A of SONN is $83.10 K
What is the all time high annual D&A for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high annual depreciation & amortization is $95.20 K
What is Sonnet BioTherapeutics Holdings annual D&A year-on-year change?
Over the past year, SONN annual depreciation & amortization has changed by +$7400.00 (+9.78%)
What is Sonnet BioTherapeutics Holdings quarterly depreciation & amortization?
The current quarterly D&A of SONN is $21.60 K
What is the all time high quarterly D&A for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high quarterly depreciation & amortization is $827.40 K
What is Sonnet BioTherapeutics Holdings quarterly D&A year-on-year change?
Over the past year, SONN quarterly depreciation & amortization has changed by +$600.00 (+2.86%)
What is Sonnet BioTherapeutics Holdings TTM depreciation & amortization?
The current TTM D&A of SONN is $83.10 K
What is the all time high TTM D&A for Sonnet BioTherapeutics Holdings?
Sonnet BioTherapeutics Holdings all-time high TTM depreciation & amortization is $850.20 K
What is Sonnet BioTherapeutics Holdings TTM D&A year-on-year change?
Over the past year, SONN TTM depreciation & amortization has changed by +$2100.00 (+2.59%)